In 2019, the FDA categorized psilocybin therapy for a breakthrough therapy for two clinical trials investigating the consequences of it on significant melancholy and major depressive ailment.The 1st identification of the mushroom was in 1838 in England and temperate locations of North The us. Outside of these areas, P. semilanceata“This is known